Risk of bias assessments for the Cochrane review 'SARS-CoV-2-neutralising monoclonal antibodies to prevent COVID-19'

Risk of bias assessment for the included randomized controlled trials.

Floor Holvast (4455169)
Btissame Massoudi (4110364)
Richard C. Oude Voshaar (122785)
Peter F. M. Verhaak (4455172)

September 2017

Based on the Cochrane Collaboration’s tool for assessing risk of bias, + indicates low risk of bi...

How to detect and reduce potential sources of biases in studies of SARS-CoV-2 and COVID-19

Accorsi, Emma K
Qiu, Xueting
Rumpler, Eva
Kennedy-Shaffer, Lee
Kahn, Rebecca
Joshi, Keya
Goldstein, Edward
Stensrud, Mats J
Niehus, Rene
Cevik, Muge
Lipsitch, Marc

March 2021

Funding: National Institute of Allergy and Infectious Diseases of the National Institutes of Health ...

Risk of bias for the randomised clinical trials according to the Cochrane tool.

Giuseppe Perinetti (819246)
Jasmina Primožič (819247)
Lorenzo Franchi (306157)
Luca Contardo (819248)

October 2015

Risk of bias for the randomised clinical trials according to the Cochrane tool.</p

Risk of bias assessments for the Cochrane review 'SARS-CoV-2-neutralising monoclonal antibodies to prevent COVID-19'

Hirsch, Caroline
Park, Yun Soo
Piechotta, Vanessa
Chai, Khai Li
Estcourt, Lise J
Monsef, Ina
Salomon, Susanne
Wood, Erica M
So-Osman, Cynthia
McQuilten, Zoe
Spinner, Christoph D
Malin, Jakob J
Stegemann, Miriam
Skoetz, Nicole
Kreuzberger, Nina

May 2022

Risk of bias assessments and support for judgement with ROB 2 tool for the Cochrane Review: SARS-CoV...

Risk of bias assessments for the Cochrane review 'SARS-CoV-2-neutralising monoclonal antibodies for treatment of COVID-19'

Kreuzberger, Nina
Hirsch, Caroline
Chai, Khai Li
Tomlinson, Eve
Khosravi, Zahra
Popp, Maria
Neidhardt, Miriam
Salomon, Susanne
Piechotta, Vanessa
Valk, Sarah J
Monsef, Ina
Wood, Erica M
So-Osman, Cynthia
Roberts, David J
McQuilten, Zoe
Estcourt, Lise J
Skoetz, Nicole

May 2021

Risk of bias assessments and support for judgement with ROB 2 tool for the Cochrane Review: SARS-CoV...

Risk of bias assessments and support for judgement with ROB 2 tool for the Cochrane Review: Systemic corticosteroids for the treatment of COVID-19.

Wagner, Carina
Griesel, Mirko
Mikolajewska, Agata
Mueller, Anika
Nothacker, Monika
Kley, Karoline
Metzendorf, Maria-Inti
Fischer, Anna-Lena
Kopp, Marco
Stegemann, Miriam
Skoetz, Nicole
Fichtner, Falk

June 2021

Risk of bias assessments and support for judgement with ROB 2 tool for the Cochrane Review: Systemic...

Risk of bias assessments and support for judgement with ROB 2 tool for the Cochrane Review: Inhaled corticosteroids for the treatment of COVID-19.

Griesel, Mirko
Wagner, Carina
Fichtner, Falk
Stegemann, Miriam
Mikolajewska, Agata
Nair, Avinash Anil
Daniel, Jefferson
Metzendorf, Maria-Inti
Skoetz, Nicole
Fischer, Anna-Lena

October 2021

Risk of bias assessments and support for judgement with ROB 2 tool for the Cochrane Review: Inhaled ...

Risk of bias assessments and support for judgement with ROB 2 tool for the Cochrane Review: Hyperimmune immunoglobulin for people with COVID-19

Kimber
Valk
Chai
Piechotta
Iannizzi
Monsef
Wood
Lamikanra
Roberts
McQuilten
So-Osman
Estcourt
Skoetz

April 2022

Risk of bias assessments and support for judgement with ROB 2 tool for the Cochrane Review: Hyperimm...

Risk of bias assessments and support for judgement with ROB 2 tool for the Cochrane Review: Remdesivir for the treatment of COVID-19

Ansems, Kelly
Grundeis, Felicitas
Dahms, Karolina
Mikolajewska, Agata
Thieme, Volker
Piechotta, Vanessa
Metzendorf, Maria-Inti
Stegemann, Miriam
Benstöm, Carina
Fichtner, Falk

July 2021

Risk of bias assessments and support for judgement with ROB 2 tool for the Cochrane Review: Remdesiv...

Risk of bias assessments for version 5 of the Cochrane review 'Convalescent plasma for people with COVID-19'

Iannizzi, Claire
Chai, Khai Li
Piechotta, Vanessa
Valk, Sarah J
Kimber, Catherine
Monsef, Ina
Wood, Erica M
Lamikanra, Abigail A
Roberts, David J
McQuilten, Zoe
So-Osman, Cynthia
Jindal, Aikaj
Cryns, Nora
Estcourt, Lise J
Kreuzberger, Nina
Skoetz, Nicole

June 2022

Risk of bias assessments and support for judgement with ROB 2 tool for the Cochrane Living Systemati...

Risk of bias assessments and support for judgement with ROB 2 tool for the Cochrane Review-Update: Systemic corticosteroids for the treatment of COVID-19.

Wagner, Carina
Griesel, Mirko
Mikolajewska, Agata
Metzendorf, Maria-Inti
Fischer, Anna-Lena
Stegemann, Miriam
Skoetz, Nicole
Fichtner, Falk
Nair, Avinash Anil
Daniel, Jefferson

April 2022

Risk of bias assessments and support for judgement with ROB 2 tool for the Cochrane Review-Update: S...

Using Risk of Bias 2 to assess results from randomised controlled trials:guidance from Cochrane

Flemyng, Ella
Moore, Theresa HM (Tess)
Boutron, Isabelle
Higgins, Julian P T
Hróbjartsson, Asbjørn
Hansen Nejstgaard, Camilla
Dwan, Kerry

July 2023

A systematic review identifies, appraises and synthesises all the empirical evidence from studies th...

Risk of bias assessment of the included studies.

Karumathil M. Murali (6274142)
Judy Mullan (3706102)
Steven Roodenrys (3706108)
Hicham C. Hassan (6274145)
Kelly Lambert (6274148)
Maureen Lonergan (3706099)

January 2019

The data presented for individual risk of bias domains are based on Cochrane ROB 2.0 tool [19] for r...

Risk of bias of each included trial assessed using the Cochrane risk of bias tool.

Renato S. Melo (11921454)
Caroline Stefany Ferreira Cardeira (16955702)
Damaris Scarleth A. Rezende (16955705)
Vinícius J. Guimarães-do-Carmo (16955708)
Andrea Lemos (7453763)
Alberto Galvão de Moura-Filho (16955711)

September 2023

Risk of bias of each included trial assessed using the Cochrane risk of bias tool.</p

Risk of bias assessment for the included randomized controlled trials.

Floor Holvast (4455169)
Btissame Massoudi (4110364)
Richard C. Oude Voshaar (122785)
Peter F. M. Verhaak (4455172)

September 2017

Based on the Cochrane Collaboration’s tool for assessing risk of bias, + indicates low risk of bi...

How to detect and reduce potential sources of biases in studies of SARS-CoV-2 and COVID-19

Accorsi, Emma K
Qiu, Xueting
Rumpler, Eva
Kennedy-Shaffer, Lee
Kahn, Rebecca
Joshi, Keya
Goldstein, Edward
Stensrud, Mats J
Niehus, Rene
Cevik, Muge
Lipsitch, Marc

March 2021

Funding: National Institute of Allergy and Infectious Diseases of the National Institutes of Health ...

Risk of bias for the randomised clinical trials according to the Cochrane tool.

Giuseppe Perinetti (819246)
Jasmina Primožič (819247)
Lorenzo Franchi (306157)
Luca Contardo (819248)

October 2015

Risk of bias for the randomised clinical trials according to the Cochrane tool.</p

Risk of bias assessments for the Cochrane review 'SARS-CoV-2-neutralising monoclonal antibodies to prevent COVID-19'

Hirsch, Caroline
Park, Yun Soo
Piechotta, Vanessa
Chai, Khai Li
Estcourt, Lise J
Monsef, Ina
Salomon, Susanne
Wood, Erica M
So-Osman, Cynthia
McQuilten, Zoe
Spinner, Christoph D
Malin, Jakob J
Stegemann, Miriam
Skoetz, Nicole
Kreuzberger, Nina

May 2022

Risk of bias assessments and support for judgement with ROB 2 tool for the Cochrane Review: SARS-CoV...

Risk of bias assessments for the Cochrane review 'SARS-CoV-2-neutralising monoclonal antibodies for treatment of COVID-19'

Kreuzberger, Nina
Hirsch, Caroline
Chai, Khai Li
Tomlinson, Eve
Khosravi, Zahra
Popp, Maria
Neidhardt, Miriam
Salomon, Susanne
Piechotta, Vanessa
Valk, Sarah J
Monsef, Ina
Wood, Erica M
So-Osman, Cynthia
Roberts, David J
McQuilten, Zoe
Estcourt, Lise J
Skoetz, Nicole

May 2021

Risk of bias assessments and support for judgement with ROB 2 tool for the Cochrane Review: SARS-CoV...

Risk of bias assessments and support for judgement with ROB 2 tool for the Cochrane Review: Systemic corticosteroids for the treatment of COVID-19.

Wagner, Carina
Griesel, Mirko
Mikolajewska, Agata
Mueller, Anika
Nothacker, Monika
Kley, Karoline
Metzendorf, Maria-Inti
Fischer, Anna-Lena
Kopp, Marco
Stegemann, Miriam
Skoetz, Nicole
Fichtner, Falk

June 2021

Risk of bias assessments and support for judgement with ROB 2 tool for the Cochrane Review: Systemic...

Risk of bias assessments and support for judgement with ROB 2 tool for the Cochrane Review: Inhaled corticosteroids for the treatment of COVID-19.

Griesel, Mirko
Wagner, Carina
Fichtner, Falk
Stegemann, Miriam
Mikolajewska, Agata
Nair, Avinash Anil
Daniel, Jefferson
Metzendorf, Maria-Inti
Skoetz, Nicole
Fischer, Anna-Lena

October 2021

Risk of bias assessments and support for judgement with ROB 2 tool for the Cochrane Review: Inhaled ...

Risk of bias assessments and support for judgement with ROB 2 tool for the Cochrane Review: Hyperimmune immunoglobulin for people with COVID-19

Kimber
Valk
Chai
Piechotta
Iannizzi
Monsef
Wood
Lamikanra
Roberts
McQuilten
So-Osman
Estcourt
Skoetz

April 2022

Risk of bias assessments and support for judgement with ROB 2 tool for the Cochrane Review: Hyperimm...

Risk of bias assessments and support for judgement with ROB 2 tool for the Cochrane Review: Remdesivir for the treatment of COVID-19

Ansems, Kelly
Grundeis, Felicitas
Dahms, Karolina
Mikolajewska, Agata
Thieme, Volker
Piechotta, Vanessa
Metzendorf, Maria-Inti
Stegemann, Miriam
Benstöm, Carina
Fichtner, Falk

July 2021

Risk of bias assessments and support for judgement with ROB 2 tool for the Cochrane Review: Remdesiv...

Risk of bias assessments for version 5 of the Cochrane review 'Convalescent plasma for people with COVID-19'

Iannizzi, Claire
Chai, Khai Li
Piechotta, Vanessa
Valk, Sarah J
Kimber, Catherine
Monsef, Ina
Wood, Erica M
Lamikanra, Abigail A
Roberts, David J
McQuilten, Zoe
So-Osman, Cynthia
Jindal, Aikaj
Cryns, Nora
Estcourt, Lise J
Kreuzberger, Nina
Skoetz, Nicole

June 2022

Risk of bias assessments and support for judgement with ROB 2 tool for the Cochrane Living Systemati...

Risk of bias assessments and support for judgement with ROB 2 tool for the Cochrane Review-Update: Systemic corticosteroids for the treatment of COVID-19.

Wagner, Carina
Griesel, Mirko
Mikolajewska, Agata
Metzendorf, Maria-Inti
Fischer, Anna-Lena
Stegemann, Miriam
Skoetz, Nicole
Fichtner, Falk
Nair, Avinash Anil
Daniel, Jefferson

April 2022

Risk of bias assessments and support for judgement with ROB 2 tool for the Cochrane Review-Update: S...

Using Risk of Bias 2 to assess results from randomised controlled trials:guidance from Cochrane

Flemyng, Ella
Moore, Theresa HM (Tess)
Boutron, Isabelle
Higgins, Julian P T
Hróbjartsson, Asbjørn
Hansen Nejstgaard, Camilla
Dwan, Kerry

July 2023

A systematic review identifies, appraises and synthesises all the empirical evidence from studies th...

Risk of bias assessment of the included studies.

Karumathil M. Murali (6274142)
Judy Mullan (3706102)
Steven Roodenrys (3706108)
Hicham C. Hassan (6274145)
Kelly Lambert (6274148)
Maureen Lonergan (3706099)

January 2019

The data presented for individual risk of bias domains are based on Cochrane ROB 2.0 tool [19] for r...

Risk of bias of each included trial assessed using the Cochrane risk of bias tool.

Renato S. Melo (11921454)
Caroline Stefany Ferreira Cardeira (16955702)
Damaris Scarleth A. Rezende (16955705)
Vinícius J. Guimarães-do-Carmo (16955708)
Andrea Lemos (7453763)
Alberto Galvão de Moura-Filho (16955711)

September 2023

Risk of bias of each included trial assessed using the Cochrane risk of bias tool.</p

Risk of bias assessment for the included randomized controlled trials.

Floor Holvast (4455169)
Btissame Massoudi (4110364)
Richard C. Oude Voshaar (122785)
Peter F. M. Verhaak (4455172)

September 2017

Based on the Cochrane Collaboration’s tool for assessing risk of bias, + indicates low risk of bi...

How to detect and reduce potential sources of biases in studies of SARS-CoV-2 and COVID-19

Accorsi, Emma K
Qiu, Xueting
Rumpler, Eva
Kennedy-Shaffer, Lee
Kahn, Rebecca
Joshi, Keya
Goldstein, Edward
Stensrud, Mats J
Niehus, Rene
Cevik, Muge
Lipsitch, Marc

March 2021

Funding: National Institute of Allergy and Infectious Diseases of the National Institutes of Health ...

Risk of bias for the randomised clinical trials according to the Cochrane tool.

Giuseppe Perinetti (819246)
Jasmina Primožič (819247)
Lorenzo Franchi (306157)
Luca Contardo (819248)

October 2015

Risk of bias for the randomised clinical trials according to the Cochrane tool.</p

Risk of bias assessments for the Cochrane review 'SARS-CoV-2-neutralising monoclonal antibodies to prevent COVID-19'

Abstract

Extracted data

Risk of bias assessments for the Cochrane review 'SARS-CoV-2-neutralising monoclonal antibodies to prevent COVID-19'

Abstract

Extracted data

Related items

Related items